Yeonsu-gu
Incheon Gwang'yeogsi
Samsung Bioepis
is a South Korea-based biopharmaceutical company that develops and commercializes biosimilar medicines... Read moreSamsung Bioepis
is a South Korea-based biopharmaceutical company that develops and commercializes biosimilar medicines... Read moreNews
Partnership
Oct 21, 2025
Manufacturing Chemist
Samsung Bioepis and Phrontline join forces to advance best-in-class antibody-drug conjugate therapeutics for solid tumours
investment
Mar 12, 2025
https://www.businesswire.com/news/home/20250313842642/en/Samsung-Invests-in-C2N-Diagnostics
Samsung Bioepis Co., Ltd. has invested $10M in C2N Diagnostics, LLC
Samsung Bioepis Competitors
1
2
3
4
5
6
7
8
9
10